# Osteolife Biomedical I LLC – FDA Inspection, Feb 13, 2026

Source: https://www.keypedia.com/records/fda_inspections/osteolife-biomedical-i-llc/cc42555d-bb87-4991-9795-ca2e6e41f2c6
Source feed: FDA_Inspections

> FDA inspection 1302716 of Osteolife Biomedical I LLC, February 13, 2026. 1 citation under 21 CFR part 1271. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1302716
- Company Name: Osteolife Biomedical I LLC
- Inspection Date: 2026-02-13
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Florida District Office
- Citation Count: 1

## Related Documents

- [FDA Inspection 1197358 - 2023-02-14](https://www.keypedia.com/records/fda_inspections/osteolife-biomedical-i-llc/eef2a42a-0d42-4d5a-a386-6797bcbfc617)
- [FDA Inspection 1161595 - 2022-02-04](https://www.keypedia.com/records/fda_inspections/osteolife-biomedical-i-llc/6bfd2c91-c8f3-4587-9338-090c61ef0329)
- [FDA Inspection 1072837 - 2018-11-28](https://www.keypedia.com/records/fda_inspections/osteolife-biomedical-i-llc/32fed49c-542d-4511-bac7-6f630477eced)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/ivan-e-reyes/69bac3eb-f63c-45f0-8420-85a7e06b884a)
- [Investigator](https://www.keypedia.com/people/nerming-v-briones/b2d9e685-a627-4f9e-854c-0588865fd1b6)

Company: https://www.keypedia.com/companies/osteolife-biomedical-i-llc/65c313b4-28a5-4ecc-875c-ac366081fdc2

Office: https://www.keypedia.com/offices/florida-district-office/95b2a118-0b78-46e0-a54c-982bd7ce51c9
